Madrigal Pharmaceuticals, Inc.
MDGL
Classement en actions
#1961
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical... Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
Prix de l'action
$465.85
Capitalisation boursière
$10.76B
Changement (1 jour)
4.20%
Changement (1 an)
5.88%
Pays
US
Échange Madrigal Pharmaceuticals, Inc. (MDGL)
Catégorie
Healthcare
Historique des divisions d’actions pour Madrigal Pharmaceuticals, Inc. (MDGL)
L’action Madrigal Pharmaceuticals, Inc. (symbole : MDGL) a subi un total de 1 divisions.
La division la plus récente a eu lieu le Jul 25, 2016.
Une action MDGL achetée avant le Jul 25, 2016 équivaudrait aujourd’hui à 0.028571428571429 actions MDGL.
La division la plus récente a eu lieu le Jul 25, 2016.
Une action MDGL achetée avant le Jul 25, 2016 équivaudrait aujourd’hui à 0.028571428571429 actions MDGL.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| 2016-07-25 | 1:35 | x0.028571428571429 | x0.028571428571429 |
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
